pharmaphorum18h
First biosimilar fast-acting insulin reaches US market
The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...
Medscape21h
FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
FDA Approves Sanofi's Merilog As First Rapid-Acting Insulin Biosimilar Product For Diabetes
Sanofi's Merilog wins FDA approval as the first rapid-acting insulin biosimilar to Novolog, offering a new option for diabetes management.
Interesting Engineering on MSN4h
FDA approves first-ever rapid-acting insulin biosimilar for diabetes treatment
First-ever rapid-acting insulin. This approval extends to a 3-milliliter single-patient-use prefilled pen and a 10-milliliter ...
February 2025's Top Insider-Owned Growth Companies
As global markets continue to grapple with inflationary pressures and fluctuating interest rates, U.S. stock indexes are nearing record highs, with growth stocks leading the charge. In this ...
Rezolute: Late-Stage Study Targeting Hyperinsulinism
Rezolute advances therapies for hypoglycemia with RZ358 and RZ402, showing efficacy in trials. Read why RZLT stock is a ...
pharmaphorum19h
Bill would allow AIs to prescribe FDA-approved drugs
The text of the bill is vanishingly short and does not give any indication of the drugs that might be prescribed by AIs or ...